Acute disseminated encephalomyelitis following vaccination against human papilloma virus

Neurology

Volumn 72, Issue 24, 2009, Pages 2132-2133

  Wildemann, B ^a   Jarius, S ^a   Hartmann, M ^a   Regula, J U ^a   Hametner, C ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; ETIRACETAM; GLYCEROL; METHYLPREDNISOLONE; THYROGLOBULIN ANTIBODY; WART VIRUS VACCINE;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CONDYLOMA ACUMINATUM; ENCEPHALOMYELITIS; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETREATMENT; TREATMENT RESPONSE; UTERINE CERVIX CANCER; VACCINATION;

EID: 67649484443     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181aa53bb     Document Type: Article

References (4)

1. Leake JA, Albani S, Kao AS, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004;23: 756-764.
2. Sutton I, Lahoria R, Tan I, Clouston P, Barnett M. CNS demyelination and quadrivalent HPV vaccination. Mult Scler 2009;15:116-119.
3. Baxter AG. The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 2007; 7:904-912.
4. Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology 2007;68:S23-S36.